In this study, we found that estrogen-induced DNMT1 increased the DNA methylation of TP53 to repress p53 expression, which positively affected DNMT1 expression, thus promoting poor prognosis of lung cancer by modulating EMT and the microenvironment. Here, DNMT1 is linked to lung cancer.